Nelfinavir is now in preliminary clinical trials, which should reveal the dose that can be tolerated by patients with cancer, and how it affects solid tumours in the body.

• 那非那韦只是临床试验的第一步，它使是我们了解癌症病人的耐药量和药物是如何影响体内坚硬的肿瘤。